Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Melanoma 35Carcinoma, Non-Small-Cell Lung 22Carcinoma, Renal Cell 20Neoplasm Metastasis 13Carcinoma, Hepatocellular 10Brain Neoplasms 8Lung Neoplasms 7Skin Neoplasms 6Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Prostatic Neoplasms 5Pancreatic Neoplasms 5Kidney Neoplasms 5Clear-cell metastatic renal cell carcinoma 5Carcinoma, Transitional Cell 5Uveal Melanoma 4Ovarian Neoplasms 4Myelodysplastic Syndromes 4Multiple Myeloma 4Mesothelioma 4Glioblastoma 4Carcinoma, Basal Cell 4Carcinoma 4Urinary Bladder Neoplasms 3Urethral Neoplasms 3Sarcoma 3Recurrence 3Liver Neoplasms 3Leukemia, Myeloid, Acute 3Histiocytoma, Malignant Fibrous 3

Interventions

Specimen Handling 12Magnetic Resonance Spectroscopy 12Temozolomide 11Radiotherapy 8Radiation 5Surgical Procedures, Operative 3Biopsy 3vorasidenib 2trametinib 2pembrolizumab 2dabrafenib 2Spinal Puncture 2Radiotherapy, Intensity-Modulated 2Genetic Therapy 2Craniotomy 2Bevacizumab 2vocimagene amiretrorepvec 1veliparib 1trastuzumab deruxtecan 1tocilizumab 1ribociclib 1lorlatinib 1atezolizumab 1abexinostat 1Vorinostat 1Transurethral Resection of Bladder 1Standard of Care 1Restraint, Physical 1Protons 1Proton Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Astrocytoma × Ipilimumab × 90 days × Clear all
NCT04145115 2026-05-29

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

National Cancer Institute (NCI)

Phase 2 Active not recruiting
37 enrolled
CNS

Astrocytoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡